4.5 Letter

Early free light chain reduction following treatment initiation predicts favorable outcome in intact immunoglobulin myeloma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Prognostic impact of rapid reduction of involved free light chains in multiple myeloma patients under first-line treatment with Bendamustine, Prednisone, and Bortezomib (BPV)

Tanja Holzhey et al.

Summary: The study results suggest that a rapid decrease in iFLC on day 8 is an early prognostic marker for newly diagnosed MM patients undergoing BPV treatment.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)

Article Medical Laboratory Technology

Assessment of Monoclonal Gammopathies by Nephelometric Measurement of Individual Immunoglobulin κ/λ Ratios

Arthur R. Bradwell et al.

CLINICAL CHEMISTRY (2009)

Article Hematology

Appraisal of immunoglobulin free light chain as a marker of response

Angela Dispenzieri et al.

Article Oncology

International uniform response criteria for multiple myeloma

B. G. M. Durie et al.

LEUKEMIA (2006)

Article Hematology

Serum free light chains for monitoring multiple myeloma

GP Mead et al.

BRITISH JOURNAL OF HAEMATOLOGY (2004)

Article Medicine, General & Internal

Review of 1027 patients with newly diagnosed multiple myeloma

RA Kyle et al.

MAYO CLINIC PROCEEDINGS (2003)